Anti‐Inflammatory Reliever Therapy in Asthma: A Review
Journal of the Royal Society of New Zealand · 2026-04 · 56 (2)
DOI: 10.1002/snz2.70015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the Royal Society of New Zealand, online erschienen am 08.03.2026. Verfasst von Richard Beasley und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Institute of New Zealand Wellington New Zealand. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Anti‐inflammatory reliever (AIR) therapy is the use of a combination 2‐in‐1 inhaler which includes a corticosteroid and a fast‐onset beta 2 ‐agonist, as a reliever therapy in asthma. The clinical research of its use to date has primarily involved the inhaled corticosteroid (ICS) budesonide together with the long‐acting beta 2 ‐agonist (LABA) formoterol, and budesonide with the short‐acting beta 2 ‐agonist (SABA) albuterol (salbutamol). Based on high‐quality evidence from randomised controlled trials of a substantial reduction in the risk of severe exacerbations, New Zealand and international guidelines recommend ICS/formoterol as the preferred reliever inhaler for use by adolescents and adults with asthma, across the range of asthma severity, rather than SABA reliever‐based regimens. Recently, international guidelines have also recommended ICS/SABA reliever as an alternative to a SABA reliever. These recommendations represent the most important paradigm change in asthma management for decades.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Research Institute of New Zealand Wellington New Zealand.
- School of Biological Sciences Victoria University Wellington Wellington New Zealand.
- Department of Respiratory Medicine University Hospitals Plymouth NHS Trust Plymouth UK.
- University of Otago Wellington Wellington New Zealand.
ORCID-Profile: Richard Beasley, Jonathan Noble
Zitieren
APA
Beasley, R., Patel, M., Oldfield, K., Hatter, L., Bruce, P., Noble, J., Eathorne, A., & Weatherall, M. (2026). Anti‐Inflammatory Reliever Therapy in Asthma: A Review. Journal of the Royal Society of New Zealand, 56(2). https://doi.org/10.1002/snz2.70015
Vancouver
Beasley R, Patel M, Oldfield K, Hatter L, Bruce P, Noble J, et al. Anti‐Inflammatory Reliever Therapy in Asthma: A Review. Journal of the Royal Society of New Zealand. 2026;56(2). doi:10.1002/snz2.70015
BibTeX
@article{Beasley2026,
author = {Beasley, Richard and Patel, Mitesh and Oldfield, Karen and Hatter, Lee and Bruce, Pepa and Noble, Jonathan and Eathorne, Allie and Weatherall, Mark},
title = {Anti‐Inflammatory Reliever Therapy in Asthma: A Review},
journal = {Journal of the Royal Society of New Zealand},
year = {2026},
volume = {56},
number = {2},
doi = {10.1002/snz2.70015}
}
EUVIMED